Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
DOI

10.1007/s40258-015-0215-0

Type

Journal article

Journal

Appl Health Econ Health Policy

Publication Date

02/2016

Volume

14

Pages

117 - 118

Keywords

Adrenergic beta-Agonists, Asthma, Bronchodilator Agents, Cost-Benefit Analysis, Humans, Scopolamine Derivatives